Outsourced Pharma Capacity Update Videos - Large Molecule

  1. Novartis Capacity Update April 2025: Large Molecule Development 4/22/2025

    Experience a global network of expertise and proven manufacturing capabilities that can help accelerate your clinical and commercial drug substance programs.

  2. Samsung Biologics Capacity Update April 2025: Large Molecule Development 4/22/2025

    Leveraging advanced technology, expertise, and flexible capacity, clients can reduce development time and costs while ensuring a smooth transition from clinical to commercial manufacturing.

  3. Boehringer Ingelheim Capacity Update April 2025: Large Molecule Development 4/22/2025

    Explore how world-class contract manufacturing expertise and global capabilities can help accelerate your biologic from development to commercial success.

  4. Leveraging Advanced Technology And Proven Expertise 4/22/2025

    By leveraging our proprietary non-viral gene insertion technology, GPEx® Lightning ensures rapid development timelines and high-yield production, making it an ideal solution for complex biologics.

  5. FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Large Molecule Development 4/22/2025

    Associate Director kojoX and Technology Development, Rasmus Petersen, presents a high-level overview of FDB’s capabilities, its global facilities network, and capacity updates for BIOLOGICS.

  6. Cytovance Capacity Update July 2024: Large Molecule Development 9/18/2024

    Centrally located in the United States, with a decades-long history in biologics development and manufacturing, Cytovance delivers ingenuity end-to-end to both large pharma and biotech clients alike.